Brazil becomes new coronavirus epicentre with most deaths for fifth straight day

Brazil becomes new coronavirus epicentre with most deaths for fifth straight day


Rio de Janeiro: Brazil announced the highest daily number of global COVID-19 deaths on Tuesday, with 1039 deaths. The country has ranked first for the fifth consecutive day.

The largest country in Latin America has become the new center of the coronavirus pandemic, and its daily death toll has soared, surpassing the United States, which has hit the hardest hit to date.

Johns Hopkins University (Johns Hopkins University) tracker said that in the past 24 hours, the number of deaths in the United States was 657. That was the third consecutive day that the country went below 700, bringing the country ’s total death toll to 98,875.

At the same time, since the Brazilian pandemic accelerated a week ago, the number of daily deaths in Brazil has exceeded 1,000, more than four times.

According to data from the Ministry of Health, Brazil has now confirmed 24,512 deaths.

Experts say that insufficient testing means that the actual number may be much higher.

Brazil has a population of 210 million and has recorded 391,222 infections, second only to the United States, with more than 1.68 million confirmed.

Brazil is suffering how to deal with this pandemic.

Far-right President Jair Bolsonaro downplayed the virus and opposed measures to stay at home, arguing that economic consequences could cause greater damage than the virus itself.

However, most state governments adhered to the guidance of the World Health Organization and shut down non-essential businesses.

At the same time, Bolsonaro will pin his hopes on hydroxychloroquine drugs, just like US President Donald Trump, he is touted as a potential strange drug against COVID-19.

The Brazilian Ministry of Health recommends that doctors in the public health system prescribe hydroxychloroquine or related drug chloroquine from the onset of COVID-19 symptoms.

The organization said on Monday that although WHO has concluded clinical trials due to concerns about the safety and effectiveness of hydroxychloroquine against coronavirus, it still adheres to the guidelines.

You may also like